The role of protein tyrosine phosphatases in colorectal cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1826, Issue 1, 2012, Pages 179-188

  Hoekstra, Elmer ^a   Peppelenbosch, Maikel P ^a   Fuhler, Gwenny M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Novel treatment targets; Protein tyrosine phosphatases; Signaling pathways

Indexed keywords

JANUS KINASE; LOW MOLECULAR WEIGTH PROTEIN TYROSINE PHOSPHATASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 13; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 4A3; PROTEIN TYROSINE PHOSPHATASE ALPHA; PROTEIN TYROSINE PHOSPHATASE H; PROTEIN TYROSINE PHOSPHATASE TYPE J; RAF PROTEIN; RAS PROTEIN; STAT PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; PROTEIN TYROSINE PHOSPHATASES; SIGNAL TRANSDUCTION;

EID: 84860283077     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2012.04.001     Document Type: Review

References (127)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
3. Boyle P., Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann. Oncol. 2005, 16:481-488.
4. Wennstrom J., Pierce E.R., McKusick V.A. Hereditary benign and malignant lesions of the large bowel. Cancer 1974, 34:850-857. (Suppl.).
5. Ostman A., Bohmer F.D. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol. 2001, 11:258-266.
6. Ostman A., Hellberg C., Bohmer F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 2006, 6:307-320.
7. Alonso A., Sasin J., Bottini N., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 2004, 117:699-711.
8. Wang Z., Shen D., Parsons D.W., Bardelli A., Sager J., Szabo S., Ptak J., Silliman N., Peters B.A., van der Heijden M.S., Parmigiani G., Yan H., Wang T.L., Riggins G., Powell S.M., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B., Velculescu V.E. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004, 304:1164-1166.
9. Korff S., Woerner S.M., Yuan Y.P., Bork P., von Knebel Doeberitz M., Gebert J. Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability. BMC Cancer 2008, 8:329.
10. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
11. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
12. Teng D.H., Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen K.L., Vinson V.L., Gumpper K.L., Ellis L., El-Naggar A., Frazier M., Jasser S., Langford L.A., Lee J., Mills G.B., Pershouse M.A., Pollack R.E., Tornos C., Troncoso P., Yung W.K., Fujii G., Berson A., Steck P.A., et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 1997, 57:5221-5225.
13. Marsh D.J., Dahia P.L., Zheng Z., Liaw D., Parsons R., Gorlin R.J., Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 1997, 16:333-334.
14. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 1997, 16:64-67.
15. Zhou X.P., Marsh D.J., Morrison C.D., Chaudhury A.R., Maxwell M., Reifenberger G., Eng C. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am. J. Hum. Genet. 2003, 73:1191-1198.
16. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
17. Langlois M.J., Bergeron S., Bernatchez G., Boudreau F., Saucier C., Perreault N., Carrier J.C., Rivard N. The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. PLoS One 2010, 5:e15742.
18. Jiang Y.A., Fan L.F., Jiang C.Q., Zhang Y.Y., Luo H.S., Tang Z.J., Xia D., Wang M. Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World J. Gastroenterol. 2003, 9:491-494.
19. Li X.H., Zheng H.C., Takahashi H., Masuda S., Yang X.H., Takano Y. PTEN expression and mutation in colorectal carcinomas. Oncol. Rep. 2009, 22:757-764.
20. Sly L.M., Rauh M.J., Kalesnikoff J., Buchse T., Krystal G. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Exp. Hematol. 2003, 31:1170-1181.
21. Bowen K.A., Doan H.Q., Zhou B.P., Wang Q., Zhou Y., Rychahou P.G., Evers B.M. PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer. Res. 2009, 29:4439-4449.
22. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 1998, 19:348-355.
23. Podsypanina K., Ellenson L.H., Nemes A., Gu J., Tamura M., Yamada K.M., Cordon-Cardo C., Catoretti G., Fisher P.E., Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:1563-1568.
24. Lu T.L., Chang J.L., Liang C.C., You L.R., Chen C.M. Tumor spectrum, tumor latency and tumor incidence of the Pten-deficient mice. PLoS One 2007, 2:e1237.
25. Zeng Q., Si X., Horstmann H., Xu Y., Hong W., Pallen C.J. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem. 2000, 275:21444-21452.
26. Cates C.A., Michael R.L., Stayrook K.R., Harvey K.A., Burke Y.D., Randall S.K., Crowell P.L., Crowell D.N. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett. 1996, 110:49-55.
27. Bardelli A., Saha S., Sager J.A., Romans K.E., Xin B., Markowitz S.D., Lengauer C., Velculescu V.E., Kinzler K.W., Vogelstein B. PRL-3 expression in metastatic cancers. Clin. Cancer Res. 2003, 9:5607-5615.
28. Matter W.F., Estridge T., Zhang C., Belagaje R., Stancato L., Dixon J., Johnson B., Bloem L., Pickard T., Donaghue M., Acton S., Jeyaseelan R., Kadambi V., Vlahos C.J. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem. Biophys. Res. Commun. 2001, 283:1061-1068.
29. Al-Aidaroos A.Q., Zeng Q. PRL-3 phosphatase and cancer metastasis. J. Cell. Biochem. 2010, 111:1087-1098.
30. Saha S., Bardelli A., Buckhaults P., Velculescu V.E., Rago C., St Croix B., Romans K.E., Choti M.A., Lengauer C., Kinzler K.W., Vogelstein B. A phosphatase associated with metastasis of colorectal cancer. Science 2001, 294:1343-1346.
31. Hatate K., Yamashita K., Hirai K., Kumamoto H., Sato T., Ozawa H., Nakamura T., Onozato W., Kokuba Y., Ihara A., Watanabe M. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. Oncol. Rep. 2008, 20:737-743.
32. Diamond R.H., Cressman D.E., Laz T.M., Abrams C.S., Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell. Biol. 1994, 14:3752-3762.
33. Forte E., Orsatti L., Talamo F., Barbato G., De Francesco R., Tomei L. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim. Biophys. Acta 2008, 1783:334-344.
34. Fiordalisi J.J., Keller P.J., Cox A.D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 2006, 66:3153-3161.
35. Jiang Y., Liu X.Q., Rajput A., Geng L., Ongchin M., Zeng Q., Taylor G.S., Wang J. Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis. Cancer Res. 2011, 71:234-244.
36. Wang H., Quah S.Y., Dong J.M., Manser E., Tang J.P., Zeng Q. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res. 2007, 67:2922-2926.
37. McParland V., Varsano G., Li X., Thornton J., Baby J., Aravind A., Meyer C., Pavic K., Rios P., Kohn M. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides. Biochemistry 2011, 50:7579-7590.
38. Yan H., Hong D., Ge X., Gao X., Han X. Generation of conditional knockout alleles for PRL-3. J. Biomed. Res. 2011, 25:438-443.
39. Rawlings J.S., Rosler K.M., Harrison D.A. The JAK/STAT signaling pathway. J. Cell Sci. 2004, 117:1281-1283.
40. Kusaba T., Nakayama T., Yamazumi K., Yakata Y., Yoshizaki A., Inoue K., Nagayasu T., Sekine I. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol. Rep. 2006, 15:1445-1451.
41. Ramponi G., Stefani M. Structure and function of the low Mr phosphotyrosine protein phosphatases. Biochim. Biophys. Acta 1997, 1341:137-156.
42. Bucciantini M., Chiarugi P., Cirri P., Taddei L., Stefani M., Raugei G., Nordlund P., Ramponi G. The low Mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase. FEBS Lett. 1999, 456:73-78.
43. Tailor P., Gilman J., Williams S., Couture C., Mustelin T. Regulation of the low molecular weight phosphotyrosine phosphatase by phosphorylation at tyrosines 131 and 132. J. Biol. Chem. 1997, 272:5371-5374.
44. de Souza Malaspina T.S., Zambuzzi W.F., dos Santos C.X., Campanelli A.P., Laurindo F.R., Sogayar M.C., Granjeiro J.M. A possible mechanism of low molecular weight protein tyrosine phosphatase (LMW-PTP) activity modulation by glutathione action during human osteoblast differentiation. Arch. Oral Biol. 2009, 54:642-650.
45. Souza A.C., Azoubel S., Queiroz K.C., Peppelenbosch M.P., Ferreira C.V. From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase. Cell. Mol. Life Sci. 2009, 66:1140-1153.
46. Giannoni E., Raugei G., Chiarugi P., Ramponi G. A novel redox-based switch: LMW-PTP oxidation enhances Grb2 binding and leads to ERK activation. Biochem. Biophys. Res. Commun. 2006, 348:367-373.
47. Chiarugi P., Cirri P., Raugei G., Camici G., Dolfi F., Berti A., Ramponi G. PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett. 1995, 372:49-53.
48. Chiarugi P., Cirri P., Taddei M.L., Giannoni E., Fiaschi T., Buricchi F., Camici G., Raugei G., Ramponi G. Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation. J. Biol. Chem. 2002, 277:37331-37338.
49. Taddei M.L., Chiarugi P., Cirri P., Buricchi F., Fiaschi T., Giannoni E., Talini D., Cozzi G., Formigli L., Raugei G., Ramponi G. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res. 2002, 62:6489-6499.
50. Rigacci S., Talini D., Berti A. LMW-PTP associates and dephosphorylates STAT5 interacting with its C-terminal domain. Biochem. Biophys. Res. Commun. 2003, 312:360-366.
51. Kikawa K.D., Vidale D.R., Van Etten R.L., Kinch M.S. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J. Biol. Chem. 2002, 277:39274-39279.
52. Malentacchi F., Marzocchini R., Gelmini S., Orlando C., Serio M., Ramponi G., Raugei G. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers. Biochem. Biophys. Res. Commun. 2005, 334:875-883.
53. Marzocchini R., Malentacchi F., Biagini M., Cirelli D., Luceri C., Caderni G., Raugei G. The expression of low molecular weight protein tyrosine phosphatase is up-regulated in 1,2-dimethylhydrazine-induced colon tumours in rats. Int. J. Cancer 2008, 122:1675-1678.
54. Dissing J., Johnsen A.H. Human red cell acid phosphatase (ACP1): the primary structure of the two pairs of isozymes encoded by the ACP1*A and ACP1*C alleles. Biochim. Biophys. Acta 1992, 1121:261-268.
55. Alho I., Clara Bicho M., Carvalho R., da Silva A.P., Costa L., Bicho M. Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility to cancer development. Cancer Genet. Cytogenet. 2008, 181:20-24.
56. Ottana R., Maccari R., Ciurleo R., Paoli P., Jacomelli M., Manao G., Camici G., Laggner C., Langer T. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors. Bioorg. Med. Chem. 2009, 17:1928-1937.
57. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006, 7:833-846.
58. Zhao Y., Zhang X., Guda K., Lawrence E., Sun Q., Watanabe T., Iwakura Y., Asano M., Wei L., Yang Z., Zheng W., Dawson D., Willis J., Markowitz S.D., Satake M., Wang Z. Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2592-2597.
59. Zhang X., Guo A., Yu J., Possemato A., Chen Y., Zheng W., Polakiewicz R.D., Kinzler K.W., Vogelstein B., Velculescu V.E., Wang Z.J. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4060-4064.
60. Tonks N.K., Diltz C.D., Fischer E.H. Purification of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem. 1988, 263:6722-6730.
61. Brown-Shimer S., Johnson K.A., Lawrence J.B., Johnson C., Bruskin A., Green N.R., Hill D.E. Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5148-5152.
62. Frangioni J.V., Beahm P.H., Shifrin V., Jost C.A., Neel B.G. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 1992, 68:545-560.
63. Liu F., Chernoff J. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem. J. 1997, 327(Pt 1):139-145.
64. Dube N., Cheng A., Tremblay M.L. The role of protein tyrosine phosphatase 1B in Ras signaling. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1834-1839.
65. Seely B.L., Staubs P.A., Reichart D.R., Berhanu P., Milarski K.L., Saltiel A.R., Kusari J., Olefsky J.M. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 1996, 45:1379-1385.
66. Buckley D.A., Cheng A., Kiely P.A., Tremblay M.L., O'Connor R. Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol. Cell. Biol. 2002, 22:1998-2010.
67. LaMontagne K.R., Flint A.J., Franza B.R., Pandergast A.M., Tonks N.K. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo. Mol. Cell. Biol. 1998, 18:2965-2975.
68. Gu F., Dube N., Kim J.W., Cheng A., Ibarra-Sanchez Mde J., Tremblay M.L., Boisclair Y.R. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling. Mol. Cell. Biol. 2003, 23:3753-3762.
69. Julien S.G., Dube N., Read M., Penney J., Paquet M., Han Y., Kennedy B.P., Muller W.J., Tremblay M.L. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat. Genet. 2007, 39:338-346.
70. Bentires-Alj M., Neel B.G. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res. 2007, 67:2420-2424.
71. Lassmann S., Weis R., Makowiec F., Roth J., Danciu M., Hopt U., Werner M. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med. (Berl.) 2007, 85:293-304.
72. Zhu S., Bjorge J.D., Fujita D.J. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res. 2007, 67:10129-10137.
73. Chen J. Is Src the key to understanding metastasis and developing new treatments for colon cancer?. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5:306-307.
74. Lieu C., Kopetz S. The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy. Clin. Colorectal Cancer 2010, 9:89-94.
75. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 2000, 351(Pt 2):289-305.
76. Ostman A., Yang Q., Tonks N.K. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9680-9684.
77. Grazia Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T.O., Dejana E. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 2003, 161:793-804.
78. Kovalenko M., Denner K., Sandstrom J., Persson C., Gross S., Jandt E., Vilella R., Bohmer F., Ostman A. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 2000, 275:16219-16226.
79. Jandt E., Denner K., Kovalenko M., Ostman A., Bohmer F.D. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion. Oncogene 2003, 22:4175-4185.
80. Palka H.L., Park M., Tonks N.K. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 2003, 278:5728-5735.
81. Omerovic J., Clague M.J., Prior I.A. Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells. Biochem. J. 2010, 426:65-72.
82. Sacco F., Tinti M., Palma A., Ferrari E., Nardozza A.P., Hooft van Huijsduijnen R., Takahashi T., Castagnoli L., Cesareni G. Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J. Biol. Chem. 2009, 284:22048-22058.
83. Lesueur F., Pharoah P.D., Laing S., Ahmed S., Jordan C., Smith P.L., Luben R., Wareham N.J., Easton D.F., Dunning A.M., Ponder B.A. Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer. Hum. Mol. Genet. 2005, 14:2349-2356.
84. Toland A.E., Rozek L.S., Presswala S., Rennert G., Gruber S.B. PTPRJ haplotypes and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:2782-2785.
85. Ruivenkamp C.A., van Wezel T., Zanon C., Stassen A.P., Vlcek C., Csikos T., Klous A.M., Tripodis N., Perrakis A., Boerrigter L., Groot P.C., Lindeman J., Mooi W.J., Meijjer G.A., Scholten G., Dauwerse H., Paces V., van Zandwijk N., van Ommen G.J., Demant P. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 2002, 31:295-300.
86. Ruivenkamp C., Hermsen M., Postma C., Klous A., Baak J., Meijer G., Demant P. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 2003, 22:3472-3474.
87. Balavenkatraman K.K., Jandt E., Friedrich K., Kautenburger T., Pool-Zobel B.L., Ostman A., Bohmer F.D. DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 2006, 25:6319-6324.
88. Stepanek O., Kalina T., Draber P., Skopcova T., Svojgr K., Angelisova P., Horejsi V., Weiss A., Brdicka T. Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148. J. Biol. Chem. 2011, 286:22101-22112.
89. Trapasso F., Drusco A., Costinean S., Alder H., Aqeilan R.I., Iuliano R., Gaudio E., Raso C., Zanesi N., Croce C.M., Fusco A. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol. 2006, 25:376-382.
90. Matozaki T., Suzuki T., Uchida T., Inazawa J., Ariyama T., Matsuda K., Horita K., Noguchi H., Mizuno H., Sakamoto C., et al. Molecular cloning of a human transmembrane-type protein tyrosine phosphatase and its expression in gastrointestinal cancers. J. Biol. Chem. 1994, 269:2075-2081.
91. Murata Y., Mori M., Kotani T., Supriatna Y., Okazawa H., Kusakari S., Saito Y., Ohnishi H., Matozaki T. Tyrosine phosphorylation of R3 subtype receptor-type protein tyrosine phosphatases and their complex formations with Grb2 or Fyn. Genes Cells 2010, 15:513-524.
92. Seo Y., Matozaki T., Tsuda M., Hayashi Y., Itoh H., Kasuga M. Overexpression of SAP-1, a transmembrane-type protein tyrosine phosphatase, in human colorectal cancers. Biochem. Biophys. Res. Commun. 1997, 231:705-711.
93. Noguchi T., Tsuda M., Takeda H., Takada T., Inagaki K., Yamao T., Fukunaga K., Matozaki T., Kasuga M. Inhibition of cell growth and spreading by stomach cancer-associated protein-tyrosine phosphatase-1 (SAP-1) through dephosphorylation of p130cas. J. Biol. Chem. 2001, 276:15216-15224.
94. Takada T., Noguchi T., Inagaki K., Hosooka T., Fukunaga K., Yamao T., Ogawa W., Matozaki T., Kasuga M. Induction of apoptosis by stomach cancer-associated protein-tyrosine phosphatase-1. J. Biol. Chem. 2002, 277:34359-34366.
95. Nagano H., Noguchi T., Inagaki K., Yoon S., Matozaki T., Itoh H., Kasuga M., Hayashi Y. Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma. Oncogene 2003, 22:4656-4663.
96. Sadakata H., Okazawa H., Sato T., Supriatna Y., Ohnishi H., Kusakari S., Murata Y., Ito T., Nishiyama U., Minegishi T., Harada A., Matozaki T. SAP-1 is a microvillus-specific protein tyrosine phosphatase that modulates intestinal tumorigenesis. Genes Cells 2009, 14:295-308.
97. Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev. 2000, 11:273-282.
98. Banville D., Ahmad S., Stocco R., Shen S.H. A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases. J. Biol. Chem. 1994, 269:22320-22327.
99. Maekawa K., Imagawa N., Nagamatsu M., Harada S. Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett. 1994, 337:200-206.
100. Saras J., Claesson-Welsh L., Heldin C.H., Gonez L.J. Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins. J. Biol. Chem. 1994, 269:24082-24089.
101. Sato T., Irie S., Kitada S., Reed J.C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995, 268:411-415.
102. Ciccarelli F.D., Bork P., Kerkhoff E. The KIND module: a putative signalling domain evolved from the C lobe of the protein kinase fold. Trends Biochem. Sci. 2003, 28:349-352.
103. Chishti A.H., Kim A.C., Marfatia S.M., Lutchman M., Hanspal M., Jindal H., Liu S.C., Low P.S., Rouleau G.A., Mohandas N., Chasis J.A., Conboy J.G., Gascard P., Takakuwa Y., Huang S.C., Benz E.J., Bretscher A., Fehon R.G., Gusella J.F., Ramesh V., Solomon F., Marchesi V.T., Tsukita S., Hoover K.B., et al. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 1998, 23:281-282.
104. Vermeer P.D., Bell M., Lee K., Vermeer D.W., Wieking B.G., Bilal E., Bhanot G., Drapkin R.I., Ganesan S., Klingelhutz A.J., Hendriks W.J., Lee J.H. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers. PLoS One 2012, 7:e30447.
105. Abaan O.D., Toretsky J.A. PTPL1: a large phosphatase with a split personality. Cancer Metastasis Rev. 2008, 27:205-214.
106. Abaan O.D., Levenson A., Khan O., Furth P.A., Uren A., Toretsky J.A. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis. Oncogene 2005, 24:2715-2722.
107. Yao H., Song E., Chen J., Hamar P. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. Br. J. Cancer 2004, 91:1718-1725.
108. Miyazaki T., Atarashi Y., Yasumura S., Minatoya I., Ogawa K., Iwamoto M., Minemura M., Shimizu Y., Sato T.A., Watanabe A., Sugiyama T. Fas-associated phosphatase-1 promotes Fas-mediated apoptosis in human colon cancer cells: novel function of FAP-1. J. Gastroenterol. Hepatol. 2006, 21:84-91.
109. Kaplan R., Morse B., Huebner K., Croce C., Howk R., Ravera M., Ricca G., Jaye M., Schlessinger J. Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:7000-7004.
110. Krueger N.X., Streuli M., Saito H. Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J. 1990, 9:3241-3252.
111. Harder K.W., Moller N.P., Peacock J.W., Jirik F.R. Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion. J. Biol. Chem. 1998, 273:31890-31900.
112. Zheng X.M., Wang Y., Pallen C.J. Cell transformation and activation of pp 60c-src by overexpression of a protein tyrosine phosphatase. Nature 1992, 359:336-339.
113. Ponniah S., Wang D.Z., Lim K.L., Pallen C.J. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr. Biol. 1999, 9:535-538.
114. Tabiti K., Smith D.R., Goh H.S., Pallen C.J. Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas. Cancer Lett. 1995, 93:239-248.
115. Zheng X., Resnick R.J., Shalloway D. Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi. Int. J. Cancer 2008, 122:1999-2007.
116. Krndija D., Schmid H., Eismann J.L., Lother U., Adler G., Oswald F., Seufferlein T., von Wichert G. Substrate stiffness and the receptor-type tyrosine-protein phosphatase alpha regulate spreading of colon cancer cells through cytoskeletal contractility. Oncogene 2010, 29:2724-2738.
117. Nilsson I., Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res. 2000, 4:107-114.
118. Boutros R., Dozier C., Ducommun B. The when and wheres of CDC25 phosphatases. Curr. Opin. Cell Biol. 2006, 18:185-191.
119. Ferguson A.M., White L.S., Donovan P.J., Piwnica-Worms H. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol. Cell. Biol. 2005, 25:2853-2860.
120. Kristjansdottir K., Rudolph J. Cdc25 phosphatases and cancer. Chem. Biol. 2004, 11:1043-1051.
121. Hernandez S., Bessa X., Bea S., Hernandez L., Nadal A., Mallofre C., Muntane J., Castells A., Fernandez P.L., Cardesa A., Campo E. Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab. Invest. 2001, 81:465-473.
122. Takemasa I., Yamamoto H., Sekimoto M., Ohue M., Noura S., Miyake Y., Matsumoto T., Aihara T., Tomita N., Tamaki Y., Sakita I., Kikkawa N., Matsuura N., Shiozaki H., Monden M. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res. 2000, 60:3043-3050.
123. Talvinen K., Tuikkala J., Gronroos J., Huhtinen H., Kronqvist P., Aittokallio T., Nevalainen O., Hiekkanen H., Nevalainen T., Sundstrom J. Biochemical and clinical approaches in evaluating the prognosis of colon cancer. Anticancer. Res. 2006, 26:4745-4751.
124. Prahallad A., Sun C., Huang S., Di Nicolantonio F., Salazar R., Zecchin D., Beijersbergen R.L., Bardelli A., Bernards R. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 2012, 483:100-103.
125. Charbonneau H., Tonks N.K., Kumar S., Diltz C.D., Harrylock M., Cool D.E., Krebs E.G., Fischer E.H., Walsh K.A. Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:5252-5256.
126. Czernilofsky A.P., Levinson A.D., Varmus H.E., Bishop J.M., Tischer E., Goodman H.M. Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature 1980, 287:198-203.
127. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001, 411:355-365.